{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/50474-350#drug","name":"KYGEVVI","alternateName":"doxecitine and doxribtimine","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"50474-350"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA219792"},{"@type":"PropertyValue","propertyID":"UNII","value":"0W860991D6|VC2W18DGKR"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"7d5ce670-9314-4fd7-8b0a-1447910dcf9e"}],"activeIngredient":"DOXECITINE, DOXRIBTIMINE","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"UCB, Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA219792","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d5ce670-9314-4fd7-8b0a-1447910dcf9e","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-350"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T20:47:15.067Z"}}